BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q4 2025

Type / Class
Equity / Common Shares, $0.001 par value
Symbol
BMEZ on NYSE
Shares outstanding
103,858,423
Price per share
$15.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
13,264,107
Total reported value
$199,640,653
% of total 13F portfolios
0%
Share change
+2,160,860
Value change
+$32,619,893
Number of holders
81
Price from insider filings
$15.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 20% $296,530,547 20,750,913 Saba Capital Management, L.P. 20 Jan 2025

As of 31 Dec 2025, 81 institutional investors reported holding 13,264,107 shares of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ). This represents 13% of the company’s total 103,858,423 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MORGAN STANLEY 2% 2,087,735 +16% 0% $31,420,412
BANK OF AMERICA CORP /DE/ 1.5% 1,563,203 +1.8% 0% $23,526,206
Penserra Capital Management LLC 1.4% 1,468,529 +10% 0.26% $22,101,000
UBS Group AG 1% 1,034,791 -3.8% 0% $15,573,605
Invesco Ltd. 0.88% 912,922 -1.7% 0% $13,739,476
WELLS FARGO & COMPANY/MN 0.68% 711,388 -4% 0% $10,706,389
RAYMOND JAMES FINANCIAL INC 0.63% 658,675 +54% 0% $9,913,058
RIVERNORTH CAPITAL MANAGEMENT, LLC 0.62% 648,567 +196% 0.46% $9,760,933
WOLVERINE ASSET MANAGEMENT LLC 0.39% 401,511 +79% 0.09% $6,042,741
LAZARD ASSET MANAGEMENT LLC 0.36% 378,550 0.01% $5,697,178
ROYAL BANK OF CANADA 0.36% 378,499 +3.2% 0% $5,697,000
READYSTATE ASSET MANAGEMENT LP 0.31% 321,259 +30% 0.21% $4,834,948
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 0.31% 317,715 +329% 0.36% $4,781,611
STIFEL FINANCIAL CORP 0.26% 266,472 -0.04% 0% $4,010,399
LPL Financial LLC 0.19% 197,992 +6.4% 0% $2,979,783
Almitas Capital LLC 0.15% 152,914 0.51% $2,301,356
OSAIC HOLDINGS, INC. 0.13% 136,969 -15% 0% $2,061,425
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 0.12% 123,390 +38% 0.27% $1,857,018
Rockefeller Capital Management L.P. 0.11% 113,060 -8% 0% $1,701,561
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.1% 99,528 +31% 0% $1,497,896
Quantedge Capital Pte Ltd 0.07% 73,454 +346% 0.53% $1,105,483
EVOLVE PRIVATE WEALTH, LLC 0.07% 73,330 0% 0.07% $1,103,617
&PARTNERS 0.07% 69,257 +341% 0.01% $1,042,312
Summit Financial, LLC 0.06% 59,833 -2.7% 0.01% $900,491
COMMONWEALTH EQUITY SERVICES, LLC 0.05% 54,776 -15% 0% $824,380

Institutional Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 13,264,107 $199,640,653 +$32,619,893 $15.05 81
2025 Q3 10,996,937 $158,604,644 +$14,291,091 $14.42 75
2025 Q2 9,983,878 $142,327,852 -$492,482,711 $14.26 74
2025 Q1 43,195,970 $643,024,868 -$17,758,702 $14.90 98
2024 Q4 44,382,868 $639,206,490 -$2,049,010 $14.40 103
2024 Q3 44,209,630 $700,279,755 -$38,868,904 $15.84 92
2024 Q2 46,594,719 $715,544,963 +$46,363,879 $15.36 91
2024 Q1 43,338,004 $710,244,943 +$57,901,848 $16.39 98
2023 Q4 39,890,303 $584,414,772 +$128,821,399 $14.65 104
2023 Q3 31,158,319 $448,963,302 +$29,652,579 $14.41 97
2023 Q2 29,017,887 $476,511,987 +$19,029,826 $16.42 90
2023 Q1 27,645,826 $461,938,614 +$22,927,447 $16.71 83
2022 Q4 26,331,960 $406,318,059 +$55,827,669 $15.43 80
2022 Q3 22,485,082 $335,703,678 +$18,231,882 $14.93 73
2022 Q2 21,632,470 $355,409,929 +$17,938,349 $16.43 77
2022 Q1 20,259,613 $406,372,063 +$35,376,780 $20.06 67
2021 Q4 18,445,245 $467,763,272 -$14,257,983 $25.36 70
2021 Q3 18,927,398 $510,660,360 +$13,501,426 $26.98 67
2021 Q2 18,425,464 $532,844,516 +$10,813,760 $28.92 67
2021 Q1 18,116,526 $476,444,640 +$138,702,824 $26.30 64
2020 Q4 12,832,855 $367,675,522 +$42,052,163 $28.65 49
2020 Q3 11,393,980 $271,777,833 +$83,226,929 $23.85 44
2020 Q2 7,914,318 $165,566,000 +$59,116,281 $20.91 38
2020 Q1 4,878,111 $87,329,000 +$87,239,000 $17.90 20